Resmed (RMD) FY2015 results: revenue $1.7 billion, up 8.0% on the year
Resmed Inc. (RMD) reported revenue of $1.7 billion for fiscal 2015, the year ended 30 June 2015, up 8.0% on the year before. Net income was $353 million, up 2.2%, and diluted earnings per share $2.47. The figures are the company's own, from the 10-K it filed with the SEC on 7 August 2015.
Revenue
$1.7 billion
+8.0% on the year
FY2009FY2015
Operating margin
24.4%
26.1% a year earlier
FY2009FY2015
Net income
$353 million
+2.2% on the year
FY2009FY2015
Diluted EPS
$2.47
+3.3% on the year
FY2009FY2015
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Revenue
1,679
1,555
1,514
+8.0%
Cost of revenue
668
565
574
+18.1%
Gross profit
1,011
990
941
+2.2%
Gross margin
60.2%
63.7%
62.1%
Research and development
115
118
120
-2.8%
Selling, general and administrative
479
450
431
+6.3%
Operating income
409
405
355
+1.0%
Operating margin
24.4%
26.1%
23.4%
Interest expense
5.8
6.1
6.4
-5.7%
Pre-tax income
436
431
385
+1.1%
Income tax
83.0
85.8
78.0
-3.2%
Effective tax rate
19.0%
19.9%
20.2%
Net income
353
345
307
+2.2%
Net margin
21.0%
22.2%
20.3%
Diluted EPS
$2.47
$2.39
$2.10
+3.3%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Operating cash flow
383
391
403
-2.1%
Capital expenditure
62.5
72.7
63.6
-14.1%
Free cash flow
321
319
339
+0.7%
Free cash flow margin
19.1%
20.5%
22.4%
Cash from investing
n/a
n/a
-78.0
Cash from financing
n/a
n/a
-154
Depreciation and amortisation
73.1
73.5
78.3
-0.5%
Share-based compensation
47.9
43.5
38.2
+10.1%
Buybacks
160
202
186
-20.7%
Dividends paid
157
142
97.2
+11.1%
Dividend per share
$1.12
$1.00
$0.68
+12.0%
Diluted shares, weighted
143m
144m
146m
-1.2%
Shares outstanding at period end
140m
140m
142m
+0.1%
Balance sheet
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Shareholders' equity
1,587
1,758
1,611
-9.7%
Debt
301
301
301
-0.1%
Other liabilities
296
302
299
-1.8%
Total liabilities and equity
2,184
2,361
2,211
-7.5%
Fixed assets
388
434
411
-10.7%
Goodwill
264
289
275
-8.7%
Intangible assets
47.1
45.2
49.6
+4.3%
Cash and equivalents
717
906
876
-20.8%
Receivables
363
360
318
+0.8%
Inventory
247
165
146
+49.2%
Other assets
158
161
135
-1.9%
Total assets
2,184
2,361
2,211
-7.5%
10-K for the year ended 30 June 2015, filed 7 August 2015: the filing.